Secondary mutations in the kinase domain of the <i> KIT</i> gene are predominant in imatinib‐resistant gastrointestinal stromal tumor
Toshirou Nishida(The University of Osaka), Seiichi Hirota(Hyogo Medical University)
Cited by 111
Related Papers
Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation
|Laboratory Investigation|2007|65
Different inhibitory effect of imatinib on phosphorylation of mitogen‐activated protein kinase and Akt and on proliferation in cells expressing different types of mutant platelet‐derived growth factor receptor‐α
|International Journal of Cancer|2004|17
Epithelioid glioblastoma with microglia features: potential for novel therapy
|Brain Pathology|2020|13
In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice
|Laboratory Investigation|2009|9